S-P3 B-Cell Immunity in Chronic GVHD

Track: BMT Tandem "Scientific" Meeting
Friday, February 13, 2015: 8:30 AM-10:00 AM
Seaport A-E (Manchester Grand Hyatt)
Chair:
Jerome Ritz, MD

Disclosures:
J. Ritz, Biothera, Clinical Advisory Board member: Advisory Board
Kiadis Pharma, Clinical Advisory Board member: Advisory Board

B-Cell Immunity in Chronic GVHD Introduction
Jerome Ritz, MD, Dana-Farber Cancer Institute, Harvard Medical School

B-Cell Directed Therapy for Chronic GVHD
Corey S. Cutler, MD, Dana-Farber Cancer Institute, Harvard Medical School